Publications by authors named "Keith J Simons"

Claim this Profile
I
In Vivo Evaluation of Taste-Masked Fast-Disintegrating Sublingual Tablets of Epinephrine Microcrystals.
Ousama Rachid, Keith J Simons, Mutasem Rawas-Qalaji

AAPS PharmSciTech· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use.
Ousama Rachid, Mutasem Rawas-Qalaji, Keith J Simons

Pharmaceutics· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epinephrine doses delivered from auto-injectors stored at excessively high temperatures.
Ousama Rachid, F Estelle R Simons, Mutasem Rawas-Qalaji, Stephen Lewis, Keith J Simons

Drug Dev Ind Pharm· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epinephrine autoinjectors: does freezing or refrigeration affect epinephrine dose delivery and enantiomeric purity?
Ousama Rachid, F Estelle R Simons, Mutasem Rawas-Qalaji, Stephen Lewis, Keith J Simons

J Allergy Clin Immunol Pract· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sublingual Diffusion of Epinephrine Microcrystals from Rapidly Disintegrating Tablets for the Potential First-Aid Treatment of Anaphylaxis: In Vitro and Ex Vivo Study.
Mutasem M Rawas-Qalaji, Shima Werdy, Ousama Rachid, F Estelle R Simons, Keith J Simons

AAPS PharmSciTech· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epinephrine doses contained in outdated epinephrine auto-injectors collected in a Florida allergy practice.
Ousama Rachid, F Estelle R Simons, Michael B Wein, Mutasem Rawas-Qalaji, Keith J Simons

Ann Allergy Asthma Immunol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adrenaline (epinephrine) microcrystal sublingual tablet formulation: enhanced absorption in a preclinical model.
Mutasem Rawas-Qalaji, Ousama Rachid, Belacryst A Mendez, Annette Losada, F Estelle R Simons, Keith J Simons

J Pharm Pharmacol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term stability of epinephrine sublingual tablets for the potential first-aid treatment of anaphylaxis.
Mutasem M Rawas-Qalaji, Ousama Rachid, F Estelle R Simons, Keith J Simons

Ann Allergy Asthma Immunol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic disposition of the insect repellent DEET and the sunscreen oxybenzone following intravenous and skin administration in rats.
Daryl J Fediuk, Tao Wang, Yufei Chen, Fiona E Parkinson, Michael P Namaka, Keith J Simons

Int J Toxicol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epinephrine (adrenaline) absorption from new-generation, taste-masked sublingual tablets: a preclinical study.
Ousama Rachid, Mutasem M Rawas-Qalaji, F Estelle R Simons, Keith J Simons

J Allergy Clin Immunol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapidly-disintegrating sublingual tablets of epinephrine: role of non-medicinal ingredients in formulation development.
Ousama Rachid, Mutasem Rawas-Qalaji, F Estelle R Simons, Keith J Simons

Eur J Pharm Biopharm· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histamine and H1-antihistamines: celebrating a century of progress.
F Estelle R Simons, Keith J Simons

J Allergy Clin Immunol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue disposition of the insect repellent DEET and the sunscreen oxybenzone following intravenous and topical administration in rats.
Daryl J Fediuk, Tao Wang, Yufei Chen, Fiona E Parkinson, Michael P Namaka, Keith J Simons

Biopharm Drug Dispos· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissolution testing of sublingual tablets: a novel in vitro method.
Ousama Rachid, Mutasem Rawas-Qalaji, F Estelle R Simons, Keith J Simons

AAPS PharmSciTech· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epinephrine (adrenaline) in anaphylaxis.
F Estelle R Simons, Keith J Simons

Chem Immunol Allergy· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epinephrine and its use in anaphylaxis: current issues.
Keith J Simons, F Estelle R Simons

Curr Opin Allergy Clin Immunol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An electronic tongue: evaluation of the masking efficacy of sweetening and/or flavoring agents on the bitter taste of epinephrine.
Ousama Rachid, F Estelle R Simons, Mutasem Rawas-Qalaji, Keith J Simons

AAPS PharmSciTech· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term stability of epinephrine dispensed in unsealed syringes for the first-aid treatment of anaphylaxis.
Mutasem Rawas-Qalaji, F Estelle R Simons, David Collins, Keith J Simons

Ann Allergy Asthma Immunol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
H1 antihistamines: current status and future directions.
F Estelle R Simons, Keith J Simons

World Allergy Organ J· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis.
Peter Vadas, Milton Gold, Boris Perelman, Gary M Liss, Gideon Lack, F Estelle R Simons, Keith J Simons

N Engl J Med· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of H1-receptor occupancy to H1-antihistamine dosing in children.
Keith J Simons, Margherita Strolin Benedetti, F Estelle R Simons, Michel Gillard, Eugene Baltes

J Allergy Clin Immunol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast-disintegrating sublingual epinephrine tablets: effect of tablet dimensions on tablet characteristics.
Mutasem M Rawas-Qalaji, F Estelle R Simons, Keith J Simons

Drug Dev Ind Pharm· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same bioavailability?
Mutasem M Rawas-Qalaji, F Estelle R Simons, Keith J Simons

Biopharm Drug Dispos· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.
Mutasem M Rawas-Qalaji, F Estelle R Simons, Keith J Simons

AAPS PharmSciTech· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis.
Mutasem M Rawas-Qalaji, F Estelle R Simons, Keith J Simons

J Allergy Clin Immunol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis